Elsevier

Neuroscience

Volume 448, 10 November 2020, Pages 1-13
Neuroscience

Modulation of Poly ADP Ribose Polymerase (PARP) Levels and Activity by Alcohol Binge-Like Drinking in Male Mice

https://doi.org/10.1016/j.neuroscience.2020.09.010Get rights and content

Highlights

  • Alcohol consumption in binge-like DID paradigm induces PARP expression and PARP activity in the PFC of C57BL/6J male mouse.

  • Virus-induced PARP1 overexpression in the PFC increases voluntary alcohol consumption in C57BL/6J male mice.

  • PARP inhibitor ABT-888 decreases voluntary alcohol consumption in C57BL/6J male mice.

  • RNA-seq of DID mice PFC samples identified genes upregulated by EtOH involved in addiction behavior and neuronal function.

  • Four genes selected based on RNA-seq results were validated via qRT-PCR as upregulated by EtOH and downregulated by ABT-888.

Abstract

Binge drinking is a frequent pattern of ethanol consumption within Alcohol Use Disorders (AUDs). Binge-like ethanol exposure increases Poly(ADP-ribose) polymerase (PARP) expression and activity. PARP enzymes have been implicated in addiction and serve multiple roles in the cell, including gene expression regulation. In this study, we examined the effects of binge-like alcohol consumption in the prefrontal cortex (PFC) of adult C57BL/6J male mice via a 4-day Drinking-in-the-Dark (DID) paradigm. The role of PARP in associated gene expression and behavioral changes was assessed by administering the PARP inhibitor ABT-888 on the last DID day. We then conducted an RNA-seq analysis of the PFC gene expression changes associated with DID-consumed ethanol or ABT-888 treatment. A separate cohort of mice was inoculated with an HSV–PARP1 vector in the PFC and subject to a DID experiment to verify whether overexpressed PARP1 increased ethanol drinking. We confirmed that alcohol increases Parp1 gene expression and PARP activity in the PFC. RNA-seq showed significantly altered expression of 41 genes by DID-consumed ethanol, and of 48 genes by ABT-888. These results were confirmed by qPCR in 7 of the 10 genes validated, 4 of which have been previously associated with addiction. ABT-888 reduced, and overexpression of PFC PARP1 increased DID ethanol consumption. In our model, alcohol binge drinking induced specific alterations in the PFC expression of genes potentially involved in addiction. Pharmacological PARP inhibition proved effective in reversing these changes and preventing further alcohol consumption. Our results suggest an involvement of ethanol-induced PARP1 in reinforcing binge-like addictive behavior.

Introduction

Alcohol Use Disorder (AUD) is among the most common mental health disorders in the US, with a 29.1% lifetime prevalence (Grant et al., 2015). Binge alcohol drinking is defined as the acquisition of a blood ethanol concentration (BEC) ≥ 80 mg/dL, generally reached after 5 drinks in men and 4 drinks in women within 2 hours (“NIAAA Council Approves Definition of Binge Drinking.” NIAAA Newsletter, Department of Health and Human Services – National Institutes of Health, Winter 2004, 3: 3). Binge alcohol drinking contributes to more than half of the deaths associated with excessive alcohol consumption, and can lead to impairments in psychosocial functioning as well as adverse health consequences, including unintentional injuries, alcohol poisoning, gastritis, etc. (Naimi et al., 2003, Stahre et al., 2014). Accumulated data from diverse studies, including human and animal behavioral studies, brain imaging, electrophysiology, and molecular and cellular observations strongly support that the prefrontal cortex (PFC) plays a critical role in addiction (Grusser et al., 2004, Heilig et al., 2017, Wolstenholme et al., 2017). However, the molecular mechanisms underlying binge alcohol drinking as well as its biochemical effects are not fully understood.

Prior studies have focused on the role of PARP activity in cell death pathways following toxic levels of ethanol exposure (Climent et al., 2002, Cherian et al., 2008). The poly (ADP-ribose) polymerase (PARP) family is composed of 18 members. Murai et al (2012) reported that PARP1 is responsible for 90–95% of PARP enzymatic activity while PARP2 contributes the remaining 5–10% (Murai et al., 2012). In mouse primary cortical neuronal cultures, we found that ethanol exposure increased PARP enzymatic activity and led to gene expression changes, and that PARP inhibitors rescued some of the ethanol-induced gene expression changes (Gavin et al., 2016), indicating that PARP enzymes may act as regulators in the biochemical response to ethanol exposure (Gavin et al., 2016).

The accepted addiction cycle model presumes that alcohol drinking induces neuroadaptive changes in the brain that lead to continued alcohol seeking, therefore perpetuating the drinking cycle (Koob, 2003). We hypothesized that ethanol-induced upregulation of PARP expression and activity may lead to changes in the brain involved in increasing the alcohol drinking behavior in an animal model of binge drinking.

In support of the role of PARP enzymes in addiction, cocaine was shown to significantly increase PARP1 expression and enzymatic activity in the nucleus accumbens, and overexpression of PARP1 increased, and PARP inhibition decreased conditioned place preference for cocaine (Scobie et al., 2014). In this study, we show evidence that alcohol drinking increases PARP gene expression and its enzymatic activity in the PFC promoting further alcohol consumption. PARP1 overexpression also increases voluntary alcohol intake; this effect is associated with increased expression of genes involved in binge alcohol drinking. These observed biomolecular effects of alcohol are reduced by PARP inhibition, and PARP inhibition reduces alcohol drinking.

Section snippets

Drinking-in-the-Dark (DID) protocol for voluntary ethanol consumption

All animal studies were conducted in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. DID was performed as previously published (Thiele and Navarro, 2014). Adult 12–16 week-old C57BL/6J male mice purchased from Jackson Laboratories were singly housed and allowed to acclimate to a reverse light–dark cycle (lights on: 20:00–8:00) for 2 weeks with ad libitum access to food and water. The animals were then randomly assigned to each

Effects of ethanol on Parp1 gene expression and PARP activity

We have previously reported that ethanol increases PARP activity in cultured cortical neurons (Gavin et al., 2016). In the present study, we determined the in vivo effects of voluntary alcohol intake on the PFC of male C57BL/6J mice on Parp1 expression. Parp1 mRNA levels measured via qRT-PCR were significantly increased by DID ethanol drinking (Fig. 2A; t13 = 4.652, p = 0.0005, n = 7–8 per group). We then tested the effect of ethanol drinking in the DID paradigm as well as the effects of an

Discussion

In the present study, we showed evidence that Parp1 mRNA is upregulated by alcohol drinking, and that the inhibition of PARP activity decreases alcohol drinking, while overexpressing PARP1 in the PFC increases alcohol consumption. We showed that Parp1 was induced in the PFC after exposure to alcohol in the DID experiment, DID ethanol consumption was reduced using the PARP inhibitor ABT-888 and increased by viral PARP1 overexpression. Taken together, these results strongly suggest that

Conflict of Interest

The authors declare no competing financial interests.

Acknowledgements

This work was supported by the Department of Veterans Affairs Merit Review Awards [BX001819] (MG) and [BX004091] (DPG), National Institutes of Health [R01AA021468], [R01AA022948] (MG), [R01AA025035] (DPG) and The NARSAD Young Investigator Award [24797] (KAC). The authors have no conflicts of interest to disclose. We thank Dr. Eric Nestler for granting us permission to use the HSV–PARP1 viral construct.

References (69)

  • T.E. Thiele et al.

    “Drinking in the dark” (DID) procedures: a model of binge-like ethanol drinking in non-dependent mice

    Alcohol

    (2014)
  • J. Traynor

    mu-Opioid receptors and regulators of G protein signaling (RGS) proteins: from a symposium on new concepts in mu-opioid pharmacology

    Drug Alcohol Depend

    (2012)
  • R. Al-Hasani et al.

    Molecular mechanisms of opioid receptor-dependent signaling and behavior

    Anesthesiology

    (2011)
  • A.A. Antolin et al.

    Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors

    Oncotarget

    (2014)
  • Y.A. Blednov et al.

    Ethanol consumption in mice lacking CD14, TLR2, TLR4, or MyD88

    Alcohol Clin Exp Res

    (2017)
  • R.M. Brown et al.

    Adenosine A(2A) receptors and their role in drug addiction

    J Pharm Pharmacol

    (2008)
  • J.A. Calvo et al.

    Parp1 protects against Aag-dependent alkylation-induced nephrotoxicity in a sex-dependent manner

    Oncotarget

    (2016)
  • A. Carrillo et al.

    Transcription regulation of TNF-alpha-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells

    Nucleic Acids Res

    (2004)
  • E.Y. Chen et al.

    Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool

    BMC Bioinf

    (2013)
  • P.P. Cherian et al.

    Ethanol-mediated DNA damage and PARP-1 apoptotic responses in cultured fetal cortical neurons

    Alcohol Clin Exp Res

    (2008)
  • E. Climent et al.

    Ethanol exposure enhances cell death in the developing cerebral cortex: role of brain-derived neurotrophic factor and its signaling pathways

    J Neurosci Res

    (2002)
  • M.A. Collins et al.

    Alcohol, phospholipase A2-associated neuroinflammation, and omega3 docosahexaenoic acid protection

    Mol Neurobiol

    (2014)
  • C. Conde et al.

    Loss of poly(ADP-ribose) polymerase-1 causes increased tumour latency in p53-deficient mice

    EMBO J

    (2001)
  • J. de Wit et al.

    Role of leucine-rich repeat proteins in the development and function of neural circuits

    Annu Rev Cell Dev Biol

    (2011)
  • C.K. Donawho et al.

    ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models

    Clin Cancer Res

    (2007)
  • S. Gaspari et al.

    RGS9-2 modulates responses to oxycodone in pain-free and chronic pain states

    Neuropsychopharmacology

    (2017)
  • D.P. Gavin et al.

    Gadd45b and N-methyl-d-aspartate induced DNA demethylation in postmitotic neurons

    Epigenomics

    (2015)
  • B.F. Grant et al.

    Epidemiology of DSM-5 alcohol use disorder: results from the national epidemiologic survey on alcohol and related conditions III

    JAMA Psychiatry

    (2015)
  • S.M. Grusser et al.

    Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics

    Psychopharmacology

    (2004)
  • P.J. Hamilton et al.

    Stereotaxic surgery and viral delivery of zinc-finger epigenetic editing tools in rodent brain

    Methods Mol Biol

    (2018)
  • S.P. Hack et al.

    Adaptations in adenosine signaling in drug dependence: therapeutic implications

    Crit Rev Neurobiol

    (2003)
  • M. Heilig et al.

    Reprogramming of mPFC transcriptome and function in alcohol dependence

    Genes Brain Behav

    (2017)
  • A. Ieraci et al.

    Nicotinamide inhibits ethanol-induced caspase-3 and PARP-1 Over-Activation And Subsequent Neurodegeneration In The Developing Mouse Cerebellum

    Cerebellum

    (2018)
  • P. Jagtap et al.

    Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors

    Nat Rev Drug Discov

    (2005)
  • Cited by (0)

    View full text